Patient Prognosis and Risk Factors in HCC and Cirrhosis

(4:23)

Imaging HCC and LI-RADS

(32:30)

Options in HCC and Liver Decompensation

(4:5)

Dr. Yang on NASH-Associated HCC and Cirrhosis in Diagnosis of Liver Cancer

(1:57)

HCC and Transplant, Presented by Neil Mehta, MD

(32:51)

Case Review: Metastatic HCC and a History of HCV

(3:59)

HCC and Liver Transplantation

(3:22)

HCC HAWKS VS ST PETERSBURG COLLEGE TITANS | MENS AND WOMENS BASKETBALL

(3:46:47)

HCC and Cholangiocarcinoma by Bachir Taouli, M.D.

(3:36)

Overview and Diagnosis of HCC

(4:32)

2nd line treatment in advanced HCC and when to switch

(26:19)

About Primary Cancer of the Liver (Hepatocellular Carcinoma, HCC)

(4:23)

Current therapies for advanced HCC and their limitations

(2:25)

Dr. Cheng on Tumor Heterogeneity in HCC and Challenges for Clinical Trials

(2:59)

HCC and CCA trials at ESMO 2023: AdvanTIG-206 and ABC-01

(3:7)

Dr Franses on the Need for Prospective Data in Second-Line HCC and Beyond

(2:1econd)

Surgical Therapy for HCC--Including Resection and Liver ... | Mahmoud El-Meteini, MD, MBBcH

(21:35)

Preview: NDAs in Ovarian Cancer and HCC, and Highlights from 2016 KCS and LUGPA Annual Meeting

(31)

Approaching a Case of Unresectable HCC with Extrahepatic Involvement

(3:24)